TRADE NEWS: Agilent Technologies Introduces Dissolution Apparatus for Pharmaceutical Quality Control

Platform Sets New Global Standard for Dissolution

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and automated applications. The new device includes an improved design that minimizes variability and improves results. Dissolution is a technique used in the pharmaceutical industry to determine the rate at which pure active pharmaceutical ingredients dissolve.

Agilent's 708-DS Dissolution Apparatus can be configured for both manual and automated applications. ...

Agilent's 708-DS Dissolution Apparatus can be configured for both manual and automated applications. (Photo: Business Wire)

“Agilent is committed to maintaining Varian’s tradition of excellence in dissolution and establishing a new standard for pharmaceutical companies and other firms operating in a global marketplace,” said Frank Riba, Agilent business manager, Dissolution Division. “The new 708-DS Dissolution Apparatus yields the sample-to-sample consistency that is critical for scientists assessing batch-to-batch performance, bioequivalency and other characteristics of their compounds.”

The 708-DS Dissolution Apparatus is available as a basic manual model and in a variety of automated configurations for high-throughput online sampling and online UV analysis. The apparatus allows for several advanced usage options, including temperature monitoring, automated dosage delivery and in-situ fiber optic analysis. Customized add-ons allow a variety of dosage types to be analyzed on the same apparatus.

The design of the 708-DS Dissolution Apparatus conforms to internationally harmonized pharmacopeia specifications for basket, paddle, rotating cylinder, intrinsic and paddle-over-disk configurations. The apparatus can test tablets, capsules and a wide variety of other dosage forms.

In addition to the dissolution apparatus hardware and software, Agilent offers users peace of mind by providing high-quality service for the DS-708 Dissolution Apparatus around the globe, including:

  • qualification documentation for the entire system;
  • trained chemists to perform the installation and qualification;
  • standard operating procedure templates;
  • technical support for drug release methods, equipment and regulatory questions; and
  • sponsorship for the vendor-neutral online Dissolution Discussion Group forum.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6511001&lang=en



CONTACT:

Agilent Technologies Inc.
Eric Endicott, +1-408-553-2005
[email protected]

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:   Technology  Hardware  Software  Health  Biotechnology  Pharmaceutical  Research  Other Science  Science

MEDIA:

Logo
 Logo
Photo
 Photo
Agilent's 708-DS Dissolution Apparatus can be configured for both manual and automated applications. (Photo: Business Wire)

Suggested Articles

The latest setback prompted Novartis-partnered Conatus to lay off 40% of its staff and begin looking for strategic alternatives.

The appointments are part of Verona’s efforts to prepare for phase 3 development of ensifentrine in chronic obstructive pulmonary disease.

Syntimmune has had a roller-coaster few years, losing CEOs, gaining new ones and then being snapped up by Alexion in 2018 for up to $1.2 billion.